ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Teva, Xenon Announce Phase II Study of Topical TV-45070 Did Not Meet Primary Endpoint
June 28, 2017Teva Pharmaceutical and Xenon Pharmaceuticals announce top-line results in a Phase II study of topical TV-45070 in patients with post-herpetic neuralgia (PHN) did not meet the primary endpoint of a statistically significant change in pain from baseline to
Pharma Sources Insight January 2025
